Reduction of salivary flow with transdermal scopolamine: a four-year experience.

@article{Talmi1990ReductionOS,
  title={Reduction of salivary flow with transdermal scopolamine: a four-year experience.},
  author={Yoav Pinhas Talmi and Yehuda Finkelstein and Yuval Zohar},
  journal={Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery},
  year={1990},
  volume={103 4},
  pages={615-8}
}
Scopoderm transdermal therapeutic system (TTS) is applied to prevent nausea and vomiting associated with motion sickness. Dry mouth is the most common side effect, appearing in up to two thirds of the patients treated. We have used this side effect to the benefit of patients with sialorrhea or with difficulties swallowing normally secreted amounts of saliva. More than 100 patients with tumors of the aerodigestive tract before and after surgery, and patients after parotidectomies, after… CONTINUE READING